Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Living alone, obesity and smoking: important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer.

Dieperink KB, Hansen S, Wagner L, Johansen C, Andersen KK, Hansen O.

Acta Oncol. 2012 Jul;51(6):722-9. doi: 10.3109/0284186X.2012.682627.

PMID:
22793038
2.
3.

Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.

Ferrer M, Suárez JF, Guedea F, Fernández P, Macías V, Mariño A, Hervas A, Herruzo I, Ortiz MJ, Villavicencio H, Craven-Bratle J, Garin O, Aguiló F; Multicentric Spanish Group of Clinically Localized Prostate Cancer.

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):421-32. doi: 10.1016/j.ijrobp.2007.12.024. Epub 2008 Mar 5.

PMID:
18325680
4.
5.

Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.

Forsythe K, Blacksburg S, Stone N, Stock RG.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):630-5. doi: 10.1016/j.ijrobp.2011.06.2013. Epub 2011 Nov 16.

PMID:
22099032
7.

Longitudinal analysis of quality of life in patients receiving conformal radiation therapy for prostate cancer.

Geinitz H, Thamm R, Scholz C, Heinrich C, Prause N, Kerndl S, Keller M, Busch R, Molls M, Zimmermann FB.

Strahlenther Onkol. 2010 Jan;186(1):46-52. doi: 10.1007/s00066-009-2023-7. Epub 2009 Dec 28.

PMID:
20082188
8.

Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.

Lilleby W, Fosså SD, Waehre HR, Olsen DR.

Int J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):735-43.

PMID:
10098428
9.
10.

Quality of life in T1-3N0 prostate cancer patients treated with radiation therapy with minimum 10-year follow-up.

Johnstone PA, Gray C, Powell CR.

Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):833-8.

PMID:
10705003
12.
13.
14.

Health-related quality of life in Japanese men with localized prostate cancer: assessment with the SF-8.

Sugimoto M, Takegami M, Suzukamo Y, Fukuhara S, Kakehi Y.

Int J Urol. 2008 Jun;15(6):524-8. doi: 10.1111/j.1442-2042.2008.02046.x. Epub 2008 Apr 15.

15.

RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?

Valicenti RK, Winter K, Cox JD, Sandler HM, Bosch W, Vijayakumar S, Michalski J, Purdy J.

Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):614-20.

PMID:
14529764
16.
17.

An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.

Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA.

J Urol. 2007 Jun;177(6):2151-6; discussion 2156. Erratum in: J Urol. 2007 Sep;178(3 Pt 1):1125.

PMID:
17509305
18.

Quality of life changes during conformal radiation therapy for prostate carcinoma.

Janda M, Gerstner N, Obermair A, Fuerst A, Wachter S, Dieckmann K, Pötter R.

Cancer. 2000 Sep 15;89(6):1322-8.

PMID:
11002229
19.

Health-related quality of life after adjuvant and salvage postoperative radiotherapy for prostate cancer - a prospective analysis.

Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Holy R, Krenkel B, Eble MJ.

Radiother Oncol. 2008 Jul;88(1):135-9. Epub 2007 Nov 19.

PMID:
18022263
20.

Cross validation of the prostate cancer radiotherapy late toxicity (PCRT) questionnaire with the expanded prostate cancer index composite (EPIC) instrument.

Rodrigues G, Bauman G, Venkatesan V, Ahmad B, Lock M, Sexton T, D'Souza D, Stitt L, Eid S.

Can J Urol. 2011 Aug;18(4):5802-10.

PMID:
21854712

Supplemental Content

Support Center